{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:29:51Z","timestamp":1785536991148,"version":"3.56.0"},"reference-count":8,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2005,10,14]],"date-time":"2005-10-14T00:00:00Z","timestamp":1129248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2005,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Preliminary clinical and experimental results suggest that iron can modify hepatocytes\u2019 insulin sensitivity by interfering with insulin receptor and intracellular insulin signalling.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To evaluate <jats:italic>in vivo<\/jats:italic> the influence of iron on insulin resistance and insulin release in patients with non\u2010alcoholic fatty liver disease and <jats:italic>in vitro<\/jats:italic> the interaction between iron and insulin sensitivity by analysing the effect of iron manipulation on insulin receptor expression in hepatoblastoma HepG2 cell line.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002Insulin resistance evaluated by homeostatis model assessment (HOMA)\u2010insulin resistance significantly decreased after diet, and a further reduction was observed after phlebotomies. Iron depletion by desferrioxamine increased by twofold the <jats:sup>125<\/jats:sup>I\u2010insulin\u2010specific binding, whereas iron addition reduced insulin binding, similarly to cells exposed to high glucose concentration.<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold> :\u2002Iron status affects insulin sensitivity by modulating the transcription and membrane expression\/affinity of insulin receptor expression in hepatocytes and influencing insulin\u2010dependent gene expression suggesting that increased insulin clearance and decreased insulin resistance may contribute to the positive effect of iron depletion in patients with non\u2010alcoholic fatty liver disease.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2005.02599.x","type":"journal-article","created":{"date-parts":[[2005,10,14]],"date-time":"2005-10-14T14:15:16Z","timestamp":1129299316000},"page":"61-63","source":"Crossref","is-referenced-by-count":76,"title":["Iron and insulin resistance"],"prefix":"10.1111","volume":"22","author":[{"given":"S.","family":"FARGION","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"DONGIOVANNI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"GUZZO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"COLOMBO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"VALENTI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"FRACANZANI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,10,14]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70401-4"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(03)00025-2"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-10-200311180-00029"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.4.1000"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50130"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02397-7"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.8.2348"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M905410199"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2005.02599.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2005.02599.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T15:41:49Z","timestamp":1695742909000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2005.02599.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,14]]},"references-count":8,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["10.1111\/j.1365-2036.2005.02599.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02599.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,14]]}}}